Publications by authors named "Scott S Sundseth"

Claim this Profile
P
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Michael Man, Suman Duvvuru, Scott S Sundseth

J Thromb Thrombolysis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.
Jacob A Doll, Megan L Neely, Matthew T Roe, Paul W Armstrong, Harvey D White, Scott S Sundseth

J Am Coll Cardiol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's Disease.
Michael W Lutz, Scott S Sundseth, Daniel K Burns, Ann M Saunders, Kathleen M Hayden

Alzheimers Dement (N Y)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles.
Allen D Roses, Michael W Lutz, Ann M Saunders, Dmitry Goldgaber, Robert Saul, Scott S Sundseth

Alzheimers Dement· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
David Erlinge, Stefan James, Suman Duvvuru, Joseph A Jakubowski, Henrik Wagner, Scott S Sundseth

Thromb Haemost· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
Conrad J Wong, Jennifer Witcher, Craig Mallinckrodt, Robert A Dean, Raymond F Anton, Scott S Sundseth

Alcohol Clin Exp Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response.
Kristi B Adamo, Robert Dent, Carl D Langefeld, Miranda Cox, Kathryn Williams, Scott S Sundseth

Obesity (Silver Spring)· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
Yi Yu, Diego F Wyszynski, Dawn M Waterworth, Steven D Wilton, Philip J Barter, Scott S Sundseth

J Lipid Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
Diego F Wyszynski, Dawn M Waterworth, Philip J Barter, Jonathan Cohen, Y Antero Kesäniemi, Scott S Sundseth

Am J Cardiol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94.
Carolyn Root, Chari D Smith, Scott S Sundseth, Heather M Pink, Joan G Wilson

J Lipid Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis